Patent Abstract:
A method for identifying an RNA form of a bacteria, comprising reverse transcribing RNA material; conducting PCR using primers for a first highly conserved genetic sequence generic of the bacteria; conducting nested PCR using primers for a second highly conserved genetic sequence within the first genetic sequence of the bacteria; and identifying the bacteria based on unconserved amplified sequences linked to the conserved sequences.

Full Description:
FIELD OF THE INVENTION  
       [0001]     The present invention relates to the field of PCR methods, and specific primers therefore, as well as their use in the identification of any type of bacteria, and in particular RNA forms of bacteria.  
       BACKGROUND OF THE INVENTION  
       [0002]     The use of biological fluids for therapeutic human application such as plasmas, albumin, live vaccines, stem cells requires that they are absolutely devoid of bacterial contamination. It has been found that filtering, and possibly other traditional methods, may fail to eliminate all forms of organisms, leading to possible contamination or experimental artifacts.  
         [0003]     It is believed that certain pathologies are associated with bacteria or bacterial forms which are difficult to detect, and which may pass through nano-porous barriers. This leads to possible errors in diagnosis or causation, and which may lead to erroneous treatment and impede prevention.  
         [0004]     See, Hopert, Anne, Uphoff, Cord C., Wirth, Manfred, Hauser, Hansjorg, and Drexler, Hans G., “Specificity and sensitivity of Polymerase Chain Reaction (PCR) in comparison with other methods for the detection of  mycoplasma  contamination in cell lines”, J. Immunological Methods, 164(1993):91-100, expressly incorporated herein by reference.  
         [0005]     Kajander, E. O., et al., “Comparison of  Staphylococci  and novel Bacteria-Like Particles from blood”, Zbl. Bakt. Suppl. 26, 1994, expressly incorporated herein by reference.  
         [0006]     Akerman, Kari K., “Scanning Electron Microscopy of Nanobacteria—Novel Biofilm Producing Organisms in Blood”, Scanning Vol. 15, Suppl. III (1993), expressly incorporated herein by reference. www.newcastle.edu.au/discipline/biology/projects/hons_cpru.html, expressly incorporated herein by reference.  
         [0007]     Cifticioglu, Neva, et al., “Apoptotic effect of nanobacteria on cultured mammalian cells”, Mol. Biol. Cell. Suppl., Vol. 7 (1996):517a  
         [0008]     Cifticioglu, Neva, et al., “A new potential threat in antigen and antibody products: Nanobacteria”, Vaccines 97, Brown et al. Ed., Cold Spring Harbor Laboratory Press, New York, 1997, expressly incorporated herein by reference.  
         [0009]     Baseman, Joel B., et al., “ Mycoplasmas:  Sophisticated, Reemerging, and Burdened by their Notoriety”, EID Vol. 3, N o  1 www.cdc.gov/ncidod/EID/vol3no1/baseman.htm, expressly incorporated herein by reference.  
         [0010]     Relman, David A., “Detection and Identification of Previously Unrecognized Microbial Pathogens”, EID Vol. 4, N o  3 www.cdc.gov/ncidod/EID/vol4no3/relman.htm, expressly incorporated herein by reference.  
         [0011]     Mattman, Lida H., Cell Wall Deficient Forms-Stealth Pathogens, 2nd Ed., CRC Press (1993), expressly incorporated herein by reference.  
         [0012]     U.S. Pat. No. 5,688,646, expressly incorporated herein by reference, describes novel  mycoplasmas  which are prominent in patients who are thought to be suffering from AIDS. Devices are also provided for the in vitro detection of  mycoplasmas  in biological fluid by means of a reagent which is specific for the  mycoplasma  group without being specific for particular species within said group. Devices for testing  mycoplasma  sensitivity to antibiotics are also described.  
         [0013]     See the following, each of which and cited references is expressly incorporated herein by reference in their entirety:  
                                             Pat. No   Title                                6,562,611   FEN-1 endonucleases, mixtures and cleavage methods       6,558,902   Infrared matrix-assisted laser desorption/ionization mass spectrometric analysis of           macromolecules       6,555,357   FEN-1 endonuclease, mixtures and cleavage methods       6,555,338   NrdF from  Staphylococcus aureus         6,537,774   UPS (undecaprenyl diphosphate synthase       6,492,113   Detection of  Mycoplasma  genus and species in patients with chronic fatigue syndrome           and fibromyalgia       6,489,139   FabZ from  Staphylococcus aureus         6,489,110   EF-Tu mRNA as a marker for viability of bacteria       6,458,572   Phosphatidylglycerophosphate synthase from  Staphylococcus aureus         6,458,535   Detection of nucleic acids by multiple sequential invasive cleavages 02       6,448,037   PgsA       6,432,703   RATC from  Streptococcus pneumoniae         6,410,286   Asparaginyl tRNA synthetase from  Staphylococcus Aureus         6,399,343   inFB       6,372,424   Rapid detection and identification of pathogens       6,361,965   YfiI pseudouridine synthase       6,353,093   gidB       6,350,600   trmD       6,348,582   Prokaryotic polynucleotides polypeptides and their uses       6,348,328   Compounds       6,348,314   Invasive cleavage of nucleic acids       6,346,397   GyrA       6,340,564   yhxB       6,331,411   TopA       6,326,172   ytgP       6,312,932   Yfil pseudouridine synthase       6,309,866   6-phosphogluconate dehydrogenase       6,303,771   Pth       6,294,652   Response regulator       6,294,357   FabF from  Staphylococcus aureus         6,287,807   MurF       6,287,804   nrdG       6,277,595   FabZ       6,274,719   Gcp       6,274,361   pth       6,270,762   tdk       6,268,177   Isolated nucleic acid encoding nucleotide pyrophosphorylase       6,261,802   Ups (ugc)       6,261,769   Intergenic spacer target sequence for detecting and distinguishing  Chlamydial  species           or strains       6,255,075   Bira       6,251,631   nadE from  Streptococcus pneumoniae         6,251,629   ABC transporter       6,248,721   Method of using mouse model for evaluation of HIV vaccines       6,245,891   nusB polypeptides and polynucleotides and methods thereof       6,245,542   tRNA methyltransferase from  Streptococcus pneumoniae         6,238,900   Polynucleotides encoding glutamyltrna synthetase from  staphylococcus aureus         6,238,887   Ribosome recycling factor (FRR) of  Staphylococcus aureus         6,238,882   GidA1       6,228,625   metK from  Streptococcus pneumoniae         6,228,584   DexB       6,210,880   Polymorphism analysis by nucleic acid structure probing with structure-bridging           oligonucleotides       6,204,014   DnaB       6,197,549   Ama       6,197,300   ftsZ       6,194,170   MurF of  Streptococcus pneumoniae         6,190,881   Ribonucleotide diphosphate reductase, nrdF, of  streptococcus pneumoniae         6,168,797   FabF       6,165,992   Histidine kinase       6,165,991   Sensor histidine kinase of  Streptococcus pneumoniae         6,165,764   Polynucleotides encoding tRNA methyl transferases from  Streptococcus pneumoniae         6,162,619   Sensor histidine kinase of  streptococcus pneumoniae         6,162,618   6-phosphogluconate dehydrogenase of  Streptococcus pneumoniae         6,156,537   Phospho-N-acetylmuramoyl-pentapeptide transferase of  Streptococcus pneumoniae         6,146,863     Staphylococcus aureus  3-hydroxyacyl-CoA dehydrogenase       6,146,846   Primosome protein a of  streptococcus pneumoniae         6,140,079   GidB       6,140,061   Response regulator       6,111,074   PyrH of  Streptococcus pneumoniae         6,110,723   Yfii pseudouridine synthase       6,110,685   infB       6,090,543   Cleavage of nucleic acids       6,060,294   Alanyl tRNA synthetase from  Staphylococcus aureus         6,001,567   Detection of nucleic acid sequences by invader-directed cleavage       5,994,111   Leucyl tRNA synthetase from  staphylococcus aureus         5,985,557   Invasive cleavage of nucleic acids       5,882,643   Lep       5,851,764   Human prostate tumor inducing gene-1 and uses thereof       5,843,669   Cleavage of nucleic acid acid using thermostable  methoanococcus jannaschii  FEN-1           endonucleases       5,843,654   Rapid detection of mutations in the p53 gene       5,795,976   Detection of nucleic acid heteroduplex molecules by denaturing high-performance           liquid chromatography and methods for comparative sequencing       5,789,217   DNA encoding asparaginyl tRNA synthetase from  staphylococcus aureus         5,786,197   Lep       5,776,750   Alanyl tRNA synthetase polynucleoyides of  staphylococcus         5,763,246   DNA encoding arginyl tRNA synthetase from  staphylococcus aureus         5,750,387   DNA encoing leucyl TRNA synthetase from  staphylococcus aureus         5,688,646     Mycoplasmas -agents for detecting and characterizing  mycoplasmas  in vitro (See           above)       6,562,957   Genomic sequence encoding endoglin and fragments thereof       6,545,140   DNA encoding an avian beta-defensin and uses thereof       6,531,148   Therapeutic agents       6,495,661   DNA encoding the outer membrane protein of  Pasteurella multocida         6,475,990   Drugs, foods or drinks with the use of algae-derived physiologically active substances       6,451,601   Transiently immortalized cells for use in gene therapy       6,403,564   Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in           patients having chronic hepatitis C infection       6,399,373   Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic           markers associated with said nucleic acid       6,368,600   Parasitic helminth cuticlin nucleic acid molecules and uses thereof       6,339,151   Enzyme catalyzed therapeutic agents       6,277,830   5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon       6,258,778   Methods for accelerating bone and cartilage growth and repair       6,248,329   Parasitic helminth cuticlin nucleic acid molecules and uses thereof       6,245,750   Enzyme catalyzed therapeutic agents       6,022,687   Diagnosis of and therapy for hereditary haemorrhagic telangiectasia       6,593,086   Nucleic acid amplification methods       6,583,266   Nucleic acid and amino acid sequences relating to  mycobacterium tuberculosis  and           leprae for diagnostics and therapeutics       6,573,068   Claudin-50 protein       6,569,647   Nucleic acid amplification method: ramification-extension amplification method           (RAM)       6,562,611   FEN-1 endonucleases, mixtures and cleavage methods       6,558,953   Grapevine leafroll virus proteins and their uses       6,558,909   Haemobartonella PCR methods and materials       6,558,905   Diagnostics and therapeutics for osteoporosis       6,558,902   Infrared matrix-assisted laser desorption/ionization mass spectrometric analysis of           macromolecules       6,555,357   FEN-1 endonuclease, mixtures and cleavage methods       6,548,633   Complementary DNA&#39;s encoding proteins with signal peptides       6,531,648   Grain processing method and transgenic plants useful therein       6,524,795   Diagnostics for cardiovascular disorders       6,521,426   Preparation of recombinant adenovirus carrying a rep gene of adeno-associated virus       6,518,020   Haemobartonella PCR methods and materials       6,503,747   Serotype-specific probes for Listeria monocytogenes       6,495,325   Detection and quantification of micro-organisms using amplification and restriction           enzyme analysis       6,458,584   Customized oligonucleotide microchips that convert multiple genetic information to           simple patterns, are portable and reusable       6,458,535   Detection of nucleic acids by multiple sequential invasive cleavages 02       6,444,876   Acyl CoA: cholesterol acyltransferase related nucleic acid sequences       6,436,399   Nucleic acid encoding the major outer membrane protein of the causative agent of           human granulocytic ehrlichiosis and peptides encoded thereby       6,432,649   Methods for detecting  Ehrlichia canis  and  Ehrlichia chaffeensis  in vertebrate and           invertebrate hosts       6,423,499   PCR primers for detection and identification of plant pathogenic species, subspecies,           and strains of acidovorax       6,403,093   Methods to detect granulocytic ehrlichiosis       6,399,307   Methods of quantifying viral load in an animal with a ribonuclease resistant RNA           preparation       6,387,617   Catalytic nucleic acid and methods of use       6,372,424   Rapid detection and identification of pathogens       6,348,314   Invasive cleavage of nucleic acids       6,329,138   Method for detection of the antibiotic resistance spectrum of mycobacterium species       6,312,922   Complementary DNAs       6,312,903   Simulataneous detection, identification and differentiation of eubacterial taxa using a           hybridization assay       6,306,653   Detection and treatment of breast disease       6,300,091   Herbicide target genes and methods       6,300,072   PCR methods and materials for detecting  bartonella  species       6,287,779   Detection of fermentation-related microorganisms       6,268,142   Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory           haplotype       6,261,773   Reagent for nucleic acid amplification and process for nucleic acid amplification       6,252,130   Production of somatic mosaicism in mammals using a recombinatorial substrate       6,251,607   PCR primers for the rapid and specific detection of  Salmonella typhimurium         6,248,519   Detection of fermentation-related microorganisms       6,221,582   Polynucleic acid sequences for use in the detection and differentiation of prokaryotic           organisms       6,214,982   Ribonuclease resistant RNA preparation and utilization       6,214,548   Diagnostic methods for Cyclospora       6,194,145   Genus and species-specific identification of  Legionella         6,180,339   Nucleic acid probes for the detection and identification of fungi       6,103,468   Rapid two-stage polymerase chain reaction method for detection of lactic acid bacteria           in beer       6,090,543   Cleavage of nucleic acids       6,033,858   Detection of transmissible spongiform encephalopathies       6,025,132   Probes targeted to rRNA spacer regions, methods and kits for using said probes, for           the detection of respiratory tract pathogens       6,001,567   Detection of nucleic acid sequences by invader-directed cleavage       6,001,564   Species specific and universal DNA probes and amplification primers to rapidly detect           and identify common bacterial pathogens and associated antibiotic resistance genes           from clinical specimens for routine diagnosis in microbiology laboratories       5,994,066   Species-specific and universal DNA probes and amplification primers to rapidly detect           and identify common bacterial pathogens and associated antibiotic resistance genes           from clinical specimens for routine diagnosis in microbiology laboratories       5,985,557   Invasive cleavage of nucleic acids       5,976,805   Neisseria gonorrhoeae specific DNA fragment-GC3       5,958,693   Extraction of DNA by boiling cells in an alkaline phenol/guanidine thiocyanate           solution       5,948,888   Neural thread protein gene expression and detection of Alzheimer&#39;s disease       5,948,634   Neural thread protein gene expression and detection of Alzheimer&#39;s disease       5,942,391   Nucleic acid amplification method: ramification-extension amplification method           (RAM)       5,939,262   Ribonuclease resistant RNA preparation and utilization       5,922,538   Genetic markers and methods for the detection of  Listeria monocytogenes  and  Listeria             spp       5,919,625   Ribonuclease resistant viral RNA standards       5,912,117   Method for diagnosis of lyme disease       5,907,085   Grapevine leafroll virus proteins and their uses       5,876,924   Nucleic acid amplification method hybridization signal amplification method (HSAM)       5,843,669   Cleavage of nucleic acid acid using thermostable  methoanococcus jannaschii  FEN-1           endonucleases       5,830,670   Neural thread protein gene expression and detection of Alzheimer&#39;s disease       5,795,976   Detection of nucleic acid heteroduplex molecules by denaturing high-performance           liquid chromatography and methods for comparative sequencing       5,763,169   Nucleic acid probes for the detection and identification of fungi       5,747,257   Genetic markers and methods for the detection of  escherichia coli  serotype-0157:H7       5,744,306   Methods for nucleic acid detection, sequencing, and cloning using exonuclease       5,734,086   Cytochrome P450.sub.lpr gene and its uses       5,707,802   Nucleic acid probes for the detection and identification of fungi       5,693,467   Mycoplasma polymerase chain reaction testing system using a set of mixed and single           sequence primers       5,688,669   Methods for nucleic acid detection, sequencing, and cloning using exonuclease       5,677,124   Ribonuclease resistant viral RNA standards       5,660,981   Selection of diagnostic genetic markers in microorganisms and use of a specific marker           for detection of  salmonella         5,658,749   Method for processing  mycobacteria         5,656,740   Nucleic acid fragments useful in the detection of  Salmonella         5,643,723   Detection of a genetic locus encoding resistance to rifampin in  mycobacterial  cultures           and in clinical specimens       5,593,836   Primers and probes for detecting  Pneumocystis carinii         5,589,570   Integrin alpha subunit cytoplasmic domain polypeptides and methods       5,518,901   Methods for adapting nucleic acid for detection, sequencing, and cloning using           exonuclease       5,310,874   Integrin .alpha. subunit cytoplasmic domain polypeptides and antibodies       20030124545   Quantitative assay for the simultaneous detection and speciation of bacterial infections       20030118992   ABC transporter       20030108873   Systems for the detection of target sequences       20030082614   Map       20030065156   Novel human genes and gene expression products I       20030059771   Compositions and methods related to the Rig tumor suppressor gene and protein       20030054338   Detection of target sequences by cleavage of non-target nucleic acids       20030044864   Cellular engineering, protein expression profiling, differential labeling of peptides, and           novel reagents therefor       20030044796   Reactions on dendrimers       20030027286   Bacterial promoters and methods of use       20030017532   ndp       20020162123   Combination immunogene therapy       20020160447   Ups (ugc)       20020150963   Map       20020146790   MurF       20020146751   fabF       20020128437   GidA1       20020127596   murF2       20020123047   dexB       20020120116     Enterococcus faecalis  polynucleotides and polypeptides       20020119520   FabZ       20020119510   gcp       20020119454   Polymorphism analysis by nucleic acid structure probing with structure-bridging           oligonucleotides       20020115075   nadE       20020106776   pth       20020102700   metK       20020098544   nrdG       20020091237   nusB       20020082234   Novel prokaryotic polynucleotides, polypeptides and their uses       20020058799   Novel pth       20020052472   ama       20020048789   birA       20020025516   NRDE       20020004581   gcp       20020004580   ftsZ       20010027183   tdk       20010023064   yfjO       20010020010   Histidine kinase       20010016334   MurF       20010014670   Treatment and diagnosis of Alzheimer&#39;s disease       20010010912   nrdF       20030145347   Grain processing method and transgenic plants useful therein       20030144490   Extended cDNAs for secreted proteins       20030144234   Methods for the treatment of chronic pain and compositions therefor       20030143684   Method of identifying inhibitors of C—C chemokine receptor 3       20030143671   Novel beta-defensins       20030143618   Method for easy cloning and selection of chimeric DNA molecules       20030143600   Detection of extracellular tumor-associated nucleic acid in blood plasma or serum           using nucleic acid amplification assays       20030143593   Quantative method for measuring gene expression       20030143577   High fidelity DNA polymerase compositions and uses therefor       20030143553   Nucleic acid amplification with direct sequencing       20030143537   Genotyping assay to predict CYP3A5 phenotype       20030143534   Probes for myctophid fish and a method for developing the same       20030143531   Detection and quantification of microorganisms using amplification and restriction           enzyme analysis       20030143241   Hepatitis E virus vaccine and method       20030143219   Nucleic acid molecules encoding a transmembrane serine protease 25, the encoded           polypeptides and methods based thereon       20030143202   Anemia       20030139590   DNA encoding SNORF25 receptor       20030138925   Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel           disease       20030138854   Method for determining BAGE expression       20030138816   Methods and kits for diagnosing the occurrence or the phase of minimal change           nephrotic syndrome (MCNS) in a human       20030138803   Identification and use of molecules implicated in pain       20030138798   Macular degeneration diagnostics and therapeutics       20030138783   Aberrantly methylated genes as markers of breast malignancy       20030138772   Method of detecting and/or identifying adeno-associated virus (AAV) sequences and           isolating novel sequences identified thereby       20030135879   Methods and materials for making and using transgenic dicamba-degrading organisms       20030134343   Specific mucin expression as a marker for pancreatic cancer       20030134310   Cellular kinase targets and inhibitors, and methods for their use       20030134301   Identification and use of molecules implicated in pain       20030134295   Method for detection of pathogenic organisms       20030134293   Method for rapid and accurate identification of microorganisms       20030134275   Telomerase reverse transcriptase (TERT) genes       20030131377   DNA molecules from maize and methods of use thereof       20030131375   Plant regulatory sequences for selective control of gene expression       20030129746   Epitopes in viral envelope proteins and specific antibodies directed against these           epitopes: use for detection of HCV viral antigen in host tissue       20030129724   Class II human histone deacetylases, and uses related thereto       20030129702   DNA encoding galanin GALR2 receptors and uses thereof       20030129687   Keratinocyte growth factor-2       20030129667   Method of diagnosing transmissible spongiform encephalopathies       20030129631   Gene family with transformation modulating activity       20030129599   Human hematopoietic growth regulatory gene and uses       20030129589   DNA diagnostics based on mass spectrometry       20030129577   Kunitz domain polypeptide Zkun8       20030129202   Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof       20030125539   DNA encoding SNORF25 receptor       20030125524   Novel cytokine zalphal 1 ligand       20030125269   T-type calcium channel       20030125258   Bone polypeptide-1       20030125248   Novel bone mineralization proteins, DNA, vectors expression systems       20030124673   Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors           therefor       20030124613   Epitope testing using soluble HLA                  
 
       SUMMARY OF THE INVENTION  
       [0014]     The present invention allows improved detection of such bacterial contaminants, including unconventional forms such as filtering forms (nanoforms), nanobacteria, and L-forms.  
         [0015]     Its principal applications are the: 
        Detection of very low levels of  mycoplasma  contamination of cell lines and biological fluids     Identification of latent bacterial infections in various pathologies     Detection of live forms passing through filters having a pore size of between 100 and 20 nm     Direct detection of RNA-containing subunits of bacteria.        
 
         [0020]     Different primers have been designed:  
         [0021]     MOLL primers have been designed initially to detect mollicutes ( mycoplasma ) species based on the conserved regions of the 16s ribosomal RNA gene. In fact they can also detect gram positive bacteria  
                                   1)   Moll Outer Primer (sense)   (AAYGGGTGAGTAACACGT),                   2)   Moll Outer Primer (antisense)   (CCCGAGAACGTATTCACCG)               3)   Moll Inner Primer (sense)   (CTACGGGAGGCAGCAGTA)               4)   Moll Inner Primer (antisense)   (GTATCTAATCCTRTTTGCTCCCCA)          
 
         [0022]     BACT primers will detect gram positive and gram negative bacteria. The sequence of MOLL primers is included in the degenerated sequence of the BACT primers.  
                               1)               Bact Outer Primer (antisense)   (CCCGRGAACGTATTCACSG),               2)       Bact Inner Primer (sense)   (CTACGGGAGGCWGCAGTRRGGAAT),               3)       Bact Inner Primer (antisense)   (WGGGTATCTAATCCTRTTTGMTCCCCW)          
 
         [0023]     The GNEG set of primers is specific of gram negative bacteria. It differs from the Moll 16 out S by a single nucleotide 
        1) Gneg Outer Primer (sense) (RAYGGGTGAGTAAYGYMT),        
 
         [0025]     The present invention therefore provides a method for identifying an RNA form of a bacteria, comprising reverse transcribing RNA material; conducting PCR using primers for a first highly conserved genetic sequence generic of the bacteria; conducting nested PCR using primers for a second highly conserved genetic sequence within the first amplified genetic sequence of the bacteria; and identifying the bacteria based on unconserved amplified sequences linked to the conserved sequences.  
         [0026]     It is believed that the Nanoforms are a stable, low metabolic rate form of bacteria, which may be related to pathology, which have characteristic DNA which is generally undetectable by PCR or nested PCR. However, these organisms do have characteristic RNA, and therefore these can be detected by nested RT-PCR. Likewise, because these are now detectable according to the present invention, it is therefore possible to monitor and optimize treatments directed toward clearing these from infected subjects.  
         [0027]     It is believed that Nanoforms are involved in human pathology, and further that these low metabolic organisms are involved in a constellation of chronic human diseases. Further, it is believed that some of these Nanoforms may be subcellular, that is, incomplete, and therefore may require association with other Nanoform, or other organisms or cells, for replication or reconstitution as a complete DNA bacterial form. Preliminary evidence suggests that the genetic material within a single Nanoforms is insufficient to reconstitute the entirety of a related bacterial (DNA) form, and therefore that multiple Nanoforms may be required in order to be self-replicating for the complete organism.  
         [0028]     For example, multiple Nanofoms may infect a single cell, together constituting a complete genome for the associated DNA bacteria. Reverse transcriptase activity, for example, due to retroviruses, endogenous retroviral sequences, DNA pol I activity, etc., may be sufficiently active to generate the bacterial genome.  
         [0029]     These Nanoforms may be biologically associated with retroviruses, such as HIV, which would therefore increase their likelihood of replication, since they would then carry their own reverse transcriptase, and potentially account for replication of sub-cellular fragments. The retroviruses may be passengers within the Nanoforms, and the Nanoforms represent an infectious particle for the virus.  
         [0030]     The present invention reveals that the Nanoforms retain conserved sequences of 16S rRNA, and therefore may be targeted on this basis, for example by tetracycline analog antibiotics, especially administered over extended durations.  
     
    
     DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS  
     Material and Methods  
       [0000]     Oligonucleotide Primers.  
         [0031]     The oligonucleotide primers used were:  
                               1)               Moll Outer Primer (sense)   (AAYGGGTGAGTAACACGT),               2)       Gneg Outer Primer (sense)   (RAYGGGTGAGTAAYGYMT),               3)       Bact Outer Primer (antisense)   (CCCGRGAACGTATTCACSG),               4)       Bact Inner Primer (sense)   (CTACGGGAGGCWGCAGTRRGGAAT), and               5)       Bact Inner Primer (antisense)   (WGGGTATCTAATCCTRTTTGMTCCCCW)         where R = G or A, S = G or C, W = A or T, M = A or C, and Y = T or C.             
 
         [0032]     Expected lengths of amplicons are ˜1,200 bp and ˜450 bp with the outer and inner primers, respectively. The primers employed were formulated as equal amounts of each primer within the class identified by the sequence.  
         [0000]     Nucleic Acid Preparation and PCR/RT-PCR.  
         [0033]     Cell line supernatants (400 μl), human plasma (200-400 μl) and human peripheral blood mononuclear cells (PBMC, 3-10 millions cells) were lyzed with 10 mM Tris, pH 7.4, 10 mM EDTA, 150 mM NaCl, 0.4% SDS, and 10 μg Proteinase K at 60° C. for 1 h. Nucleic samples were extracted three times with one volume of phenol/chloroform and one time with chloroform and precipitated by addition of 1/10 volume of 3M sodium acetate and two volumes of ethanol at −60° C. for 1 h. Samples were centrifuged 30 min. and the nucleic acid pellets were washed with 70% cold ethanol and solubilized in 10 mM Tris-HCI, pH 8.0. These preparations were stored at −60° C.  
         [0034]     PCR reaction mix (50 μl) consisted of 5 mM MgCl2, 50 mM Tris, pH 8.0, 15 mM (NH4)2SO4, 10 mM B-Mercaptoethanol, 500 μM dATP, dCTP, dGTP, and DTTP, 0.025% BSA, 1 μM of each outer primer, 1 U Taq polymerase (Roche Molecular biochemicals, Laval, Canada), and 5-10 μl nucleic acid sample. For the first round PCR, the denaturation, annealing, and elongation temperatures and times used were 95° C. for 30 s, 42° C. for 30 s, and 78° C. for 2 m, respectively, for 42 cycles. After the final cycle, the products were kept at 78° C. for 10 m. One μl of the PCR product was subjected to a second round PCR with the set of inner primers. Denaturation, annealing, and elongation temperatures and times used were 95° C. for 30 s, 47° C. for 30 s, and 78° C. for 1 m, respectively, for 42 cycles, followed by a single incubation at 78° C. for 10 m. After the first and second round PCR, 10 μl of PCR product was analyzed by gel electrophoresis using 1.5% agarose, stained with ethidium bromide, visualized under ultraviolet light and photographed. Visible bands with appropriate size were cut and sequenced using the inner primers (DNA Landmarks, St-Jean sur le Richelieu, Canada). Sequence homology search was performed using the BLAST program of the NIH web site.  
         [0035]     Samples negative for the appropriate band by PCR were subjected to a first round RT-PCR followed by a second round PCR. RT-PCR reaction mix (50 μl) consisted of 5 mM MgCl2, 50 mM Tris, pH 8.0, 15 mM (NH4)2SO4, 10 mM B-Mercaptoethanol, 500 μM dATP, dCTP, dGTP, and DTTP, 0.025% BSA, 1 μM of each outer primer, and Titan enzyme mix (Roche Molecular biochemicals, Laval, Canada), and 5 μl nucleic acid sample. The reverse transcription step was performed at 42° C. for 30 m. The first and second rounds PCR were performed as described above.  
         [0036]     The precautions addressed elsewhere (Kwok and Higuchi, 1989) were followed to minimize the risk of false-positive results caused by the carry-over of previously amplified DNA. For example, extraction of nucleic acids and preparation of PCR/RT-PCR mix were performed under a sterile flow bench, only aliquoted reagents and filter tips were used, and negative controls were incorporated into each run.  
       Results  
       [0000]     All Samples:  
         [0037]     First round PCR/RT-PCR: no detection of expected amplicon (˜1,200 bp).  
         [0038]     Second round PCR (nested-PCR): all amplicon (˜450 bp) sequences related to bacterial 16S ribosomal RNA gene.  
         [0000]     Patients&#39; Lymphocytes (18 Samples):  
         [0039]     No 450 bp amplicon detected by nested-PCR from first round PCR.  
         [0040]     All samples positive (450 bp) by nested-PCR from RT-PCR.  
         [0041]     Therefore, bacteria are in an “RNA state”, and are referred to herein as “Nanoforms”.  
         [0000]     Samples of Patients&#39; Plasma:  
         [0042]     11 samples/12 positive for 450 bp amplicon by nested-PCR from first round PCR.  
       Discussion  
       [0043]     Cell wall deficient pathogenic microorganisms, which may be  mycoplasma,  so-called L-forms, or potentially other types, are difficult to detect. Therefore, their involvement in pathology may be vastly under-reported.  
         [0044]     It has been found, however, that these organisms have a well-conserved RNA sequences, such as the 16S rRNA, even when corresponding DNA or RNA is undetectable by a traditional polymerase chain reaction (PCR) or reverse transcriptase PCR (RT-PCR) method, which may be detected by nested RT-PCR amplification, using primers according to the present invention.  
         [0045]     The present invention therefore provides a sensitive and specific method for detecting bacterial forms, which may be called “Nanoforms”, even when traditional methods fail. This therefore allows diagnosis of pathogens previously unrecognized, and monitoring of treatment thereof.

Technology Classification (CPC): 2